PGR vs ZYME · P/E 10, rev $87.67B vs rev $76.3M
Progressive Corp (PGR) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
PGR currently screens at market cap $119.28B and trailing P/E 10.4. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the PGR and ZYME stock pages for the full models.
Not investment advice.